Partnerships Press Releases

10.10.2011

Exonhit enters into Research Agreement with Pfizer to identify Alzheimer’s disease biomarkers

10.05.2011

Pfizer Announces Licensing Agreement With Puma Biotechnology, Inc. For The Development And Commercialization Of Neratinib, An Investigational Pan-HER Inhibitor

10.05.2011

Lpath Granted Two Additional U.S. Patents Related to iSONEP and ASONEP Drug Programs

10.03.2011

Medimmune'in(Licenses'cancer'immunotherapy'tremelimumab'from'pfizer

09.28.2011

International Structural Genomics Consortium Announces $48.9 MILLION in Additional Funding to Continue the Search for New Medicines

09.09.2011

Lpath Initiates Dosing of iSONEP in First of Two Proof-ofConcept Trials

08.29.2011

Jennewein Biotechnologie and Pfizer Nutrition Collaborate on Human Milk Components

08.16.2011

QIAGEN and Pfizer partner to develop companion diagnostic for novel compound in global clinical trials for lung Cancer

08.03.2011

Biotica regains worldwide rights to its rapamycin analogue program

07.07.2011

Pfizer To Explore Strategic Alternatives For Its Animal Health And Nutrition Businesses

07.05.2011

A prototype Handheld Device that Analyses DNA to Predict How Patients May Respond to their Prescription Medication has Performed Well in a Preliminary Pilot Study, Researchers Announce Today.

07.05.2011

Cell Signaling Technology, Inc. Grants a Patent License to Pfizer